Wednesday, October 15, 2008

neuMirRx Corp. Obtains Rights to Novel Drug Formulation Technology

Oct 15, 2008 - neuMirRx Corp today welcomed the issuance of U.S. patent 7,345,093, entitled "Methods for Enhancing Solubility of Compounds" which covers novel formulation methods to enhance the solubility of hydrophobic compounds. The rights to this patent and related proprietary technology, the neuNanoParticle(TM), have been obtained by neuMirRx Corp through an exclusive license arrangement with Formatech, Inc. of Andover, Massachusetts.

The details can be read here.

No comments: